Anavex Life Sciences Corp. (AVXL)

CIK 1314052 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Anavex Life Sciences Corp..

Recent SEC filings

FiledFormAccession number
Sep 10, 2026DFAN14A0001493152-26-042019
Sep 10, 2026DFAN14A0001493152-26-042192
Sep 9, 20268-K0001731122-26-001211
Sep 9, 2026DFAN14A0001493152-26-041997
Sep 8, 2026DEFA14A0001731122-26-001207
Sep 4, 2026DEFA14A0001731122-26-001194
Sep 4, 2026DFAN14A0001493152-26-041425
Sep 3, 2026DFAN14A0001493152-26-041287
Sep 2, 2026DFAN14A0001493152-26-041140
Sep 2, 20268-K0001731122-26-001179
Sep 1, 2026DEFA14A0001731122-26-001175
Aug 31, 2026DEFA14A0001731122-26-001171
Aug 28, 202610-Q0001731122-26-001166
Aug 28, 202610-K/A0001731122-26-001164
Aug 28, 202610-Q/A0001731122-26-001165
Aug 28, 202610-Q0001731122-26-001167
Aug 27, 2026DEFC14A0001493152-26-040438
Aug 27, 2026PRRN14A0001493152-26-040286
Aug 25, 20268-K0001731122-26-001143
Aug 24, 2026DEFA14A0001731122-26-001126
Aug 20, 2026DFAN14A0001493152-26-039269
Aug 18, 2026PRRN14A0001493152-26-038835
Aug 17, 20268-K0001731122-26-001078
Aug 17, 2026DEFA14A0001731122-26-001083
Aug 17, 2026DEFA14A0001731122-26-001080